Paper40552115
TRIM22 promotes glioblastoma development by ubiquitinating Bcl-2.
Zhang J and 8 others. Mol Cell Oncol, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. TRIM22 promotes glioblastoma development by ubiquitinating Bcl-2. Papers, record 40552115. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40552115
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35409068 | Atypical Ubiquitination and Parkinson's Disease. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35409068 | PubMed |
| 2 | 37155079 | Morroniside inhibits Beclin1-dependent autophagic death and Bax-dependent apoptosis in cardiomyocytes through repressing BCL2 phosphorylation. | In Vitro Cell Dev Biol Anim | 2023 | https://conductscience.org/library/papers/37155079 | PubMed |
| 3 | 38597418 | Irradiated riboflavin over nonradiated one: Potent antimigratory, antiproliferative and cytotoxic effects on glioblastoma cells. | J Cell Mol Med | 2024 | https://conductscience.org/library/papers/38597418 | PubMed |
| 4 | 35327659 | Acetylation, Phosphorylation, Ubiquitination (Oh My!): Following Post-Translational Modifications on the Ubiquitin Road. | Biomolecules | 2022 | https://conductscience.org/library/papers/35327659 | PubMed |
| 5 | 37176148 | Ubiquitination Links DNA Damage and Repair Signaling to Cancer Metabolism. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37176148 | PubMed |
| 6 | 30876462 | CoCl2 simulated hypoxia induce cell proliferation and alter the expression pattern of hypoxia associated genes involved in angiogenesis and apoptosis. | Biol Res | 2019 | https://conductscience.org/library/papers/30876462 | PubMed |
| 7 | 21264255 | The antiviral spectra of TRIM5α orthologues and human TRIM family proteins against lentiviral production. | PLoS One | 2011 | https://conductscience.org/library/papers/21264255 | PubMed |
| 8 | 38275298 | The E3 ligase TRIM22 restricts SARS-CoV-2 replication by promoting proteasomal degradation of NSP8. | mBio | 2024 | https://conductscience.org/library/papers/38275298 | PubMed |
| 9 | 35582442 | Drug resistance in glioblastoma: are persisters the key to therapy? | Cancer Drug Resist | 2020 | https://conductscience.org/library/papers/35582442 | PubMed |
| 10 | 11417471 | Unwinding the loop of Bcl-2 phosphorylation. | Leukemia | 2001 | https://conductscience.org/library/papers/11417471 | PubMed |
| 11 | 35343654 | RNF115 Inhibits the Post-ER Trafficking of TLRs and TLRs-Mediated Immune Responses by Catalyzing K11-Linked Ubiquitination of RAB1A and RAB13. | Adv Sci (Weinh) | 2022 | https://conductscience.org/library/papers/35343654 | PubMed |
| 12 | 35367198 | Regulation of IRF3 activation in human antiviral signaling pathways. | Biochem Pharmacol | 2022 | https://conductscience.org/library/papers/35367198 | PubMed |
| 13 | 33402098 | Beyond K48 and K63: non-canonical protein ubiquitination. | Cell Mol Biol Lett | 2021 | https://conductscience.org/library/papers/33402098 | PubMed |
| 14 | 33767426 | The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the STING-IFN-β pathway. | Nat Immunol | 2021 | https://conductscience.org/library/papers/33767426 | PubMed |
| 15 | 28362427 | Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo. | Cell Death Differ | 2017 | https://conductscience.org/library/papers/28362427 | PubMed |
| 16 | 36313628 | The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. | Front Oncol | 2022 | https://conductscience.org/library/papers/36313628 | PubMed |
| 17 | 32296023 | The role of ubiquitination in tumorigenesis and targeted drug discovery. | Signal Transduct Target Ther | 2020 | https://conductscience.org/library/papers/32296023 | PubMed |
| 18 | 29020630 | Degradation of Bcl-2 by XIAP and ARTS Promotes Apoptosis. | Cell Rep | 2017 | https://conductscience.org/library/papers/29020630 | PubMed |
| 19 | 31795422 | Transcriptional Regulation of INSR, the Insulin Receptor Gene. | Genes (Basel) | 2019 | https://conductscience.org/library/papers/31795422 | PubMed |
| 20 | 37039677 | The SFTSV Nonstructural Proteins Induce Autophagy to Promote Viral Replication via Interaction with Vimentin. | J Virol | 2023 | https://conductscience.org/library/papers/37039677 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42388852 | TRIM22-mediated ubiquitin-dependent degradation of FLT3-ITD overcomes TKI resistance in acute myeloid leukemia. | Life Med | 2026 | https://conductscience.org/library/papers/42388852 |
Source PubMed
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BCL2 | 596 | PubTator's text mining | https://conductscience.org/library/genes/596 | NCBI Gene |
| TRIM22 | 10346 | PubTator's text mining | https://conductscience.org/library/genes/10346 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40552115
GET https://conductscience.org/api/papers/v1/40552115/references?page=2